首页    期刊浏览 2024年11月24日 星期日
登录注册

文章基本信息

  • 标题:Preclinical Toxicity Studies of RISUGadv as A New Molecule for the Prevention and Management of Prostate Cancer
  • 本地全文:下载
  • 作者:Rama Kant Singh ; Falgun Wanganuji Bansode ; Sharad Sharma
  • 期刊名称:International Journal of Innovative Research in Science, Engineering and Technology
  • 印刷版ISSN:2347-6710
  • 电子版ISSN:2319-8753
  • 出版年度:2017
  • 卷号:6
  • 期号:7
  • 页码:12845
  • DOI:10.15680/IJIRSET.2017.0607053
  • 出版社:S&S Publications
  • 摘要:The aim of this study was to assess the toxic effect of the newly developed contraceptive RISUGadv inmale Charles Foster rats. Young and healthy male rats of Charles Foster strain were employed in the study. They wererandomly assigned to two groups, control and treated, each consisting of fifteen animals. The contraceptive DMSO andRISUGadv was injected surgically in the vas deferens of the anesthetized control and treated group rats, respectivelyand observed for a period of 14 days. Initial and final body weights and food/water consumption of the animals wererecorded. The haematological and biochemical parameters were analyzed. At the end of the study all the animals weresacrificed and necropsied, the organ weight was taken and their histopathological slides were prepared for microscopicexamination. Results on body weight, food and water consumption, haematology, biochemistry, absolute and relativeorgan weights did not show any significant change and were well within the limit of normalcy. General health checkup,mortality, gross and microscopic examination of organs and tissues also did not reveal any sign of toxicity. Fromthe toxicity point of view this newly developed injectable contraceptive RISUGadv does not have any adverse effectand is safe to use.
  • 关键词:RISUGadv; Male contraceptive agent; Toxicity profile.
国家哲学社会科学文献中心版权所有